Overview | Attendees | Agenda | Speakers | Sponsors | Location | Register

Operating as a Global Biotech

Hosted by: Perkins Coie LLP

Date: November 19 (Wednesday), 2008

Location: Perkins Coie Office, Beijing

Time: 08:30 --- 12:00

        

Overview

You are invited to attend the “Operating as a Global Biotech” Executive Workshop as the guest of our hosts and sponsors: Perkins Coie, WSGR, BPBC, ChinaBio® Accelerator and ChinaBio® Today.

This workshop addresses four critical topics for executives and investors building global biotech and life science companies in the current challenging financial climate:

• Structuring Global Life Science Company

How to structure your company to make it attractive to U.S. and China investors and provide rule-of-law and shareholder rights

• Building A Global Patent Portfolio

How to secure China, U.S. and international patents that provide freedom to operate while blocking your competition

• Reducing Drug Development Costs Through Outsourcing

How to leverage China CROs to outsource pre-clinical and clinical development to minimize costs and maximize return on investment

• Attracting Investment Capital

How to position your company to attract investment from many of the private and government funding sources available in China as well as the U.S.

To register online for this FREE workshop please click here or contact us.

Who Should Attend

Join other key executives and managers of biotechnology and life science companies interested in learning how to leverage China to raise investment funds, develop new drugs or medical devices, generate global intellectual property rights, and manage global clinical trials.

Learn “how to do it” from our speakers who are all senior executives who have successfully put their principles into practice in the real world.  Also meet other executives and managers from companies facing the same issues as you.

Agenda

Speakers

James Zhu, PhD, JD – Partner, Perkins Coie
	Dr. James Zhu is a partner in the firm's IP group and the chief representative for the Beijing office. He is also one of the key members in the firm for establishing the Shanghai office. Dr. Zhu's practice focuses on patent procurement, patent opinion, patent due diligence, intellectual property infrastructure, patent litigation, and technology licensing. He received his PhD in biology from California Institute of Technology, and his law and business degrees from Columbia University.
Wei Zhou, PhD, JD - Partner, Wilson Sonsini Goodrich & Rosati
	Dr. Wei Zhou is a partner at Wilson Sonsini Goodrich & Rosati, P.C., a leading law firm focusing on technology and growth company legal issues, where he focuses on corporate and intellectual property issues facing life sciences companies in the United States and China. Previously, he was the vice president of intellectual property and advanced technology at Affymetrix Inc. (Santa Clara, CA). Dr. Zhou obtained his JD from Stanford Law School and his PhD from Virginia Tech. He is also a graduate of the General Management Program at Harvard Business School.
Tina Huang, PhD – Acting General Manager, Beijing Site & Senior Director of Corporate Development, Bridge Laboratories
	Dr. Tina Huang has over 18 years of experience in the life science and financial fields. At Bridge, she is in charge of global corporate development activities, including business development, joint venture negotiation, IPO planning, merge and acquisition opportunities, and PR. As Acting General Manager, Dr. Huang is also responsible for the operation of Bridge Beijing facility. She holds a PhD degree from State University of New York in Molecular Biology and Biochemistry.
Greg B. Scott – President and founder, ChinaBio Accelerator
	Mr. Scott has helped launch over thirty life science startups in the US and China as a founder, investor and advisor. He founded the ChinaBio® Accelerator to help fund and mentor early stage life science companies in China. Mr. Scott is also the president and co-founder of Life Science Angels, and executive editor of ChinaBio® Today. Mr. Scott previously held senior management positions with PricewaterhouseCoopers, Capgemini and MCI.

Location

This Executive Workshop will be held at:                                                         

Perkins Coie LLP
7th Floor, Units 706 & 707, Beijing Jia Hua Center Tower E

No. 9 Shangdi Third Avenue, Haidian District

Beijing
Tel: 86-10-6296-0888

Map and Directions

      ·     Take I-80 E towards BAY BRIDGE/OAKLAND/SEVENTH STREET/(US-101 NORTH) 

·     Merge onto I-80 EAST

·     Take the FOURTH STREET exit towards EMBARCADERO

·     Merge onto BRYANT STREET

·     Turn left onto 3RD STREET

·     3RD STREET becomes KEARNY STREET

·     Turn right onto CALIFORNIA STREET. The main entrance to 555 California Street will be half way down the block on your right.

·     To access the building's parking lot, one must go around the block to the PINE STREET entrance to the building (CALIFORNIA to MONTGOMERY, right on MONTGOMERY, right on PINE STREET).

Sponsors

·      Perkins Coie Perkins Coie is a leading, full-service international law firm. With more than 600 lawyers in 15 offices across the United States and China, the firm represents clients that range in size from FORTUNE 100 companies to start-ups, and has historically represented market leaders in traditional and cutting-edge technology industries. www.perkinscoie.com

·      Wilson Sonsini Goodrich & RosatiWilson Sonsini Goodrich & Rosati is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past four decades, Wilson Sonsini Goodrich & Rosati has established its reputation in life science by having an unmatched knowledge of and deep and long-standing contacts in the industry. www.wsgr.com

·      Beijing Pharma & Biotech Center (BPBC)BPBC is a Beijing municipal governmental agency dedicated to stimulating innovation, promoting industrial development and providing consultation services to the Beijing pharma and biotech industry. www.newlife.org.cn

·      ChinaBio® Today – ChinaBio® Today is an email and web newsletter focused on the rapidly evolving biotech industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events. Free email subscriptions are available at www.ChinaBioToday.com.

About ChinaBio® Accelerator

ChinaBio® Accelerator was created to accelerate the globalization of China's biotechnology industry by:

·          Providing early stage funding to China life science companies;

·          Increasing China entrepreneurs’ success rate by mentoring and providing strategic support;

·          Developing business partnership and sales development opportunities with the West; and

·          Expanding professional networks through introductions to investors, partners, customers and media.

ChinaBio® is identifying promising biotech and medical device investment opportunities in China and providing the capital, connections and leadership to help entrepreneurs realize their vision.  www.ChinaBioLLC.com

Register

To register online for this FREE workshop please click here or contact us.